Healthcare spending is on the rise throughout the GCC (Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Oman and Bahrain). In the UAE, more and more private players are being encouraged to enter the healthcare sector. Healthcare spending in the country is expected to rise from last year’s 10.7 billion to USD to 19.5 billion USD by 2020, according to a recent report by Alpen Capital.
In Saudi Arabia, the pharmaceutical market is expected to grow from its total 2015 value of 4.5 billion USD to 6 billion USD by 2020, representing a compound annual growth rate of 7.4 percent. The Saudi Ministry of Health is expected to spend 18.5 billion USD on healthcare every year for the next 10 years.
Adam Dion, GlobalData’s senior analyst covering industry dynamics, said “Due to the increase of chronic diseases and Saudi Arabia’s rising wealth, there is a huge demand for patented products, representing a significant opportunity for market players.”
As the regional healthcare market grows, the demand for affordable and effective medicine, medical technology and healthcare services is rising as well. Investors from around the GCC are able and willing to invest in healthcare companies overseas, particularly those with products that show potential for successful distribution in the GCC market.
Naseba is a deal facilitator with offices in Dubai, Chicago and Bangalore, and a presence in many other countries globally. We have spent over a decade building a network of contacts with investors from around the world – including the GCC. This network includes family offices, sovereign wealth funds, investment firms, high net worth individuals and members of royalty.
Our investor analyst team speaks to investors on a daily basis in order to fully understand their needs and mandates. The team is currently sourcing US healthcare investment opportunities on behalf of these investors.
On 4th and 5th, October 2016, we will be organising a private investor meeting in Dubai and Riyadh to introduce pre-screened GCC investors to pre-qualified US healthcare investment opportunities.
Submit your business case:
Oops! We could not locate your form.
To learn more, contact:
Naseba investor introduction
+971 4 455 7954